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The origin of specificity and insight into
recognition between an aminoacyl carrier protein
and its partner ligase†
Aleksandra Marsˇavelski,*a Marko Mocˇibob,b Ita Gruic´-Sovuljb and Robert Vianello*a
Acyl carrier proteins (ACPs) are among the most promiscuous proteins in terms of protein–protein inter-
actions and it is quite puzzling how ACPs select the correct partner between many possible upstream
and downstream binding proteins. To address this question, we performed molecular dynamics simula-
tions on dimeric Bradyrhizobium japonicum Gly:CP ligase 1 to inspect the origin of its selectivity towards
the three types of carrier proteins, namely holoCP, apoCP, and holoCP–Gly, which only differ in the
attached prosthetic group. In line with experiments, MM-GBSA analysis revealed that the ligase
preferentially binds the holoCP form to both subunits with the binding free energies of 20.7 and
19.1 kcal mol1, while the apoCP form, without the prosthetic group, is also recognized, but the
binding values of 9.2 and 3.6 kcal mol1 suggest that there is no competition for the ligase binding
as long as the holoCP is present. After the prosthetic group becomes glycylated, the holoCP–Gly dis-
sociates from the ligase, as supported by its endergonic binding free energies of 2.9 and 20.9 kcal mol1.
Our results indicate that these affinity differences are influenced by three aspects: the form of the pros-
thetic group and the specific non-polar hydrophobic interactions, as well as charge complementarity
dominantly manifested through Arg220–Glu53 ion pair within the binding region among proteins. A
careful examination of the bonding patterns within the ligase active site elucidated the interactions with
Arg258, Asp215 and Tyr132 as being predominant in stabilizing the prosthetic group, which are signifi-
cantly diminished upon glycation, thus promoting complex dissociation.
1. Introduction
Acyl carrier proteins (ACPs) are involved in a number of path-
ways of primary and secondary cell metabolism. Some of them
function as stand-alone proteins in biosynthetic pathways, while
others form a domain of large multidomain fatty acid or poly-
ketide synthases. Also, there are peptidyl carrier proteins (PCP)
as well as aryl carrier proteins (ArCPs) of nonribosomal peptide
synthetases (NRPSs), which produce a large number of natural
bioactive peptides in nucleic acid-independent mechanisms.
ACPs are expressed as apoACPs and are activated to holoACPs
by the corresponding ACP synthase (ACPS), which catalyzes the
attachment of a 40-phosphopantetheine (Ppant) moiety to the
conserved Ser residue. This makes the Ppant prosthetic group
(Scheme 1) a common feature of all acyl carrier proteins, through
which ACPs are capable of binding, sequestering and delivering
attached intermediates to a downstream acceptor protein or
protein domain in numerous metabolic pathways. ACPs provide
acyl groups for both lipid A1 and lipoic acid synthesis,2 and
they participate in quorum sensing, bioluminescence and toxin
activation.3–6 Moreover, together with PCPs, ACPs also take part
in the polyketide and non-ribosomal peptide syntheses, which
Scheme 1 Chemical structure of the Ppant prosthetic group and its amino-
acylated derivative Ppant–Gly, both chemically bound to the Ser residue of
the carrier protein. The numbering of atoms relevant for the discussion is
indicated in round brackets.
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produce important secondary metabolites, such as lipopeptide
antibiotic daptomycin and iron carrying siderophore entero-
bactin.7,8 Considering a large number of pathways in which
ACPs participate, it is apparent that there are dozens of various
partner proteins that interact with them. Thus, it remains a
challenge to understand how ACPs both select and discrimi-
nate between appropriate partner proteins or partner domains,
since they are among most promiscuous proteins in terms of
protein–protein interactions in the cell.9
It is presumed that the overall acidic nature of ACPs is the
basis for interaction with their partner enzymes.10 Indeed,
complementary basic regions, which form electrostatic inter-
actions with the acidic helix II of ACP, have been identified
in several enzymes in Escherichia coli fatty acid synthase II
(FAS II).11 Thus, helix II of ACP is named as the ‘‘recognition
helix’’ and it serves as a universal interaction site on ACP.12 The
role of helix II became first apparent from the crystal structure
of ACP complexed with holo-acyl carrier protein synthase (AcpS)
from Bacillus subtilis.13 Moreover, the importance of these acidic
residues has been further confirmed through extensive site-
directed mutagenesis.14 In order to investigate the binding inter-
actions between carrier protein and one of its protein partners,
we choose a recently described complex formed between amino-
acyl carrier protein from Bradyrhizobium japonicum (Bj CP) and
its B. japonicum glycine:[carrier protein] partner ligase 1 (Bj Gly:CP
ligase 1).15 Bj CP binds to Bj Gly:CP ligase 1 and attaches the glycyl
moiety, derived from glycyl-adenilate formed in the active site of
ligase, to the terminal –SH group of its Ppant moiety (Scheme 1).
Subsequently, Bj CP, carrying the glycyl fragment, dissociates
from Bj Gly:CP ligase 1 and delivers glycine to a downstream
partner protein in a yet uncharacterized metabolic pathway.15
Recently published results15 have undoubtedly shown that,
when both holo- and apoCP forms are present, biologically
relevant recognition is achieved only between holoCP and Bj
Gly:CP ligase 1, the latter interacting with moderate affinity
(KD = 21.5 mM), as determined through a set of pull down
experiments, as well as kinetic analysis and isothermal titration
calorimetry (ITC) measurements. In this work, we were inter-
ested in elucidating the distinct features of the carrier protein
in its apo and holo forms that govern the preferential binding
of holoCP to Bj Gly:CP ligase 1, and rationalize the differing
affinities of the ligase towards three ACP forms. Furthermore,
since Bj Gly:CP ligase 1 is a dimer capable of binding one
carrier protein per subunit (Fig. 1), we sought to find if subunits
exhibit different bindings towards the same form of the carrier
protein. Although the previously published co-crystal structure
of holoCP and Bj Gly:CP ligase 115 provided global information
about the interacting interfaces of these two proteins, the ques-
tions mentioned above remained to be answered.
2. Methods
2.1 System preparation
The initial models for the molecular dynamics (MD) simulations
were prepared using the three-dimensional structures determined
by the X-ray diﬀraction. Two crystal structures of the enzyme
B. japonicum Gly:CP ligase 1 in a complex with analogue of glycyl-
adenylate bound to the cognate carrier protein (PDB ID code
4H2T, resolution 2.44 Å) and without it (PDB ID code 3MF1,
resolution 2.20 Å) were both considered in setting up the initial
models of the ligase interacting with its cognate carrier proteins.
HoloCP–Gly bound to the ligase was modeled from the structure
of B. japonicum glycine:[carrier protein] ligase complexed with
the glycylated carrier protein (PDB ID code 4H2V, resolution
2.00 Å), while a complex of apoCP and Bj Gly:CP ligase 1 was
modeled by deleting 4-phosphopantethein (Ppant) prosthetic
group attached on an invariant serine residue of holoCP complexed
with B. japonicum Gly:CP ligase 1 (PDB ID code 4H2T, resolution
2.44 Å). In all cases, the missing residues were built using the
I-TASSER server.16–18 Altogether we prepared five molecular
models for MD simulations (Table 1), which are all heteromeric
complexes involving a dimeric ligase complexed with either two
respective carrier proteins or two isolated prosthetic groups,
symmetrically occupying both of its subunits (Fig. 1).
2.2 Molecular dynamics simulations
The missing hydrogen atoms in the prepared models were added
using the tleap module in AMBER12.19 The geometries of both
the 40-phosphopantetheine prosthetic group bound to the serine
residue and an analogue of glycyl-adenylate were optimized using
the HF/6-31G* level of theory in the Gaussian 09 program,20 after
which the atomic partial charges were obtained by fitting the
electrostatic potentials using the RESP fitting technique21 avail-
able in AMBER12. Prepared models (Table 1) were employed as
the initial structures for the MD simulations. The general AMBER
force field GAFF22 and the AMBER ﬀ12SB force field23 were
used for the substrate and the protein complexes, respectively.
All structures were subsequently solvated in a truncated octa-
hedral box of TIP3P water molecules spanning a 10 Å thick
Fig. 1 The structure of holoCP – Bj Gly : CP ligase 1 2 : 1 complex. Both
holoCPs are given in red, while Bj Gly:CP ligase 1 is shown in blue with
CP-binding helices given in yellow. Ppant prosthetic groups are given in
the licorice representation.
Table 1 Molecular models used in the molecular dynamics simulations
Model number Molecular model
1 apoCP:Bj Gly:CP ligase 1:apoCP
2 holoCP:Bj Gly:CP ligase 1:holoCP
3 holoCP–Gly:Bj Gly:CP ligase 1:holoCP–Gly
4 Ppant:Bj Gly:CP ligase 1:Ppant
5 Ppant–Gly:Bj Gly:CP ligase 1:Ppant–Gly
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buﬀer of solvent around each protein. We carried out energy
minimizations and MD simulations using the PMEMDmodule.
Production runs, each 60 ns in length, were performed on GPU
using the pmemd.CUDA engine.24–26 Protein geometry optimiza-
tion was conducted in four cycles with different constraints. In the
first cycle (1500 steps), water molecules and the substrate were
relaxed, while the protein and zinc cation were constrained using
a harmonic potential with a force constant of 32 kcal (mol Å2)1.
In the second (2500 steps), third (1500 steps), and fourth cycle
(5000 steps), the same force constant was applied to the zinc
cation, and the value of 10 kcal (mol Å2)1 was imposed to
constrain the protein backbone. The energy minimization
procedure, consisting of 470 steps of the steepest descent
followed by the conjugate gradient algorithm for the remaining
optimization steps, was the same in all cycles. Optimized
systems were gradually heated from 0 to 300 K and equilibrated
during 30 ps using NVT conditions, and subjected to productive,
unconstrained MD simulations at constant temperature (300 K)
and pressure (1 atm). The temperature was held constant using a
Langevin thermostat with a collision frequency of 1 ps1. For the
first 6 ns of the productive MD run, a time step of 1 fs was used
and for the rest of MD simulations the time step was 2 fs. Bonds
involving hydrogen atoms were constrained using the SHAKE
algorithm.27 Structures were sampled every 1 ps over the first
6 ns and every 0.5 ps for the remaining 60 ns. The Particle
Mesh Ewald method28 was applied to calculate long-range
electrostatic interactions. The nonbonded interactions were
truncated at 10.0 Å.
2.3 MM-GBSA free energy calculations
The binding free energies for the Bj Gly:CP ligase 1–Bj CP
complexes, DGbind, were calculated according to the following:
DGbind = hGcomplexi  hGligasei  hGcarrier_proteini (1)
where the symbol hi denotes the average value over 100 snapshots
collected from the last 2 ns along each converged MD trajectory
(Fig. S1, ESI†). The free energy of a system,Gcomplex/ligase/carrier_protein,
can be approximated by three terms: the energy of the system in the
gas phase, solvation free energy, and entropic contribution:
Gcomplex/ligase/carrier protein = EMM + Gsolv  TDSMM (2)
where EMM, the gas-phase molecular mechanical energy, is
calculated as the sum of Einternal, EvdW, and Eelec contributions.
Gsolv, the solvation free energy is the sum of polar (Gpolar) and
nonpolar (Gnonpolar) components, where the former was calcu-
lated by solving the finite-diﬀerence Generalized Born equation,
while the latter was determined on the basis of the solvent-
accessible surface area (SASA) using the following equation:
Gnonpolar = gSASA + b
employing the recommended empirical parameters g =
0.0054 kcal mol1 Å2 and b = 0.92 kcal mol1.29 The solute
conformational entropy (SMM) was estimated by the normal-
mode analysis. Free energy calculations were performed using
the python script, MMPBSA.py30 provided in AMBER12. We
have used the modified GB model ‘‘OBC’’ with the parameters
endowed by Onufriev and coworker (igb = 2).31 The exterior and
solute dielectric constants were set to 80 and 1, respectively.32
According to the thermodynamic cycle depicted in Fig. 2, we
performed calculations on apoCP, holoCP, and holoCP–Gly
proteins bound to Bj Gly:CP ligase 1 in order to clarify the
differences in their binding free energies relative to each ligase
subunit (Fig. 1).
MM-GBSA analysis has been carried out on six complexes,
which diﬀer in the choice of the form of the considered carrier
protein (holoCP, apoCP, or holoCP–Gly) and the ligase subunit
they are bound to (A or B), the latter assigned according to the
PDB structures. As an illustrative example, both alternatives for
the holoCP system are depicted in Fig. 3. Additionally, four model
complexes involving isolated Ppant and Ppant–Gly prosthetic
groups, each placed in both ligase subunits, were also analyzed
to assess their influence on the overall binding.
2.4 Computational alanine scanning of protein–protein
interfaces
Experiments have shown that the basic CP-binding helix (residues
R220-Q232) of Bj Gly:CP ligase 1 determines macromolecular
recognition with acidic carrier protein.15 Wild-type Bj Gly:CP
ligase 1 recognizes and binds the cognate Bj carrier protein with
a moderate aﬃnity of KD = 21.5 mM, while the enthalpy change
with Bj Gly:CP ligase 1 and non-cognate carrier protein from
A. tumefaciens (At) was not measurable. After the construction of
the hybrid Bj ligase, where the CP-binding helix was replaced
with the corresponding region from A. tumefaciens Ala:CP ligase,
the selectivity of such a hybrid ligase was fully changed in favor
of At CP, while Bj CP was no longer a partner to the ligase.
Fig. 2 Thermodynamic cycle used in MM-GBSA calculations. Blue surfaces
represent calculations conducted in the aqueous solution.
Fig. 3 The structures of holoCP carrier protein bound to subunits A (left)
and B (right) of Bj Gly:CP ligase 1.
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In addition, upon deleting the CP-binding helix region, inter-
actions with either cognate or heterologous carrier proteins were
lost.15 Such strong experimental evidence that the CP-binding
helix of Bj Gly:CP ligase 1 is principally responsible for the
selection among number of possible carrier protein partners
prompted us to use the in silico alanine scanning approach to
probe the individual contribution of each residue within the
mentioned region.33,34
It has been demonstrated that protein–protein interactions
are critically dependent on just a few residues termed as ‘‘hot
spots’’ at the interface, which exert a predominant contribution
to the binding free energy,35,36 and which, if mutated, could
disrupt the interaction. On the other hand, the majority of
interface residues have a minimal effect on the binding upon
alanine mutation. Alanine scanning mutagenesis investigates
both the structural and energetic characteristics of protein–
protein interactions by mutating individual amino acids to
alanine and then scoring the impact of each mutation on the
overall binding free energy (DDGbind) among proteins. Alanine
has a propensity for forming alpha helices but it can also occur
in beta sheets. Since mutations to the alanine residue retain the
b-carbon, thus wild-type flexibility, it follows that the polypeptide
backbone conformations and, above all, secondary structure
composition stay unchanged. For this work, residues are classi-
fied as hot spots if their mutation to alanine resulted in 10-fold
or higher change in the DDGbind.
37
2.5 Sequence analysis
Sequences of aa:CP ligases were retrieved from the NCBI Protein
database. The database was searched by PSI-BLAST, using an
interactively built profile in order to retrieve all relevant sequences
deposited in the database. Altogether, 806 sequences were retrieved
after the BLAST search. To remove the redundancy of the initial
dataset, sequences exceeding 90% identity to any other sequence
were eliminated. The final sequence dataset contained 180
sequences which were aligned by ClustaX 2.1 and analysed.
2.6 Data analysis
Structures (RMSD, hydrogen bonds, distances) of the protein
complexes were analyzed using the ptraj module38 available in
the AmberTools12 and VMD,39 the latter also employed for the
visualization together with the Pymol software.40 Graphs were
plotted using the Xmgrace41 program. The analysis of the
hydrogen-bonding occupancies along the MD trajectory was
performed by employing the hydrogen bond donor–acceptor
distance of 3.5 Å and the donor–hydrogen–acceptor angle of
1351 as the cutoff values.
3. Results and discussion
3.1 Total binding free energies
We employed the MM-GBSA method to estimate the absolute
binding free energies for the protein complexes and to obtain
detailed information about energetic contributions that govern
protein–protein interactions (Table 2). Looking first at the
overall binding free energies, it turns out that both subunits of
the ligase strongly favor binding to the holoCP form, as evidenced
by DGbind values of 20.7 and 19.1 kcal mol1, respectively,
providing a convincing explanation why, in the crystal structures,
both Bj Gly:CP ligase 1 subunits are occupied with the holoCP
form. Partitioning of the overall interaction energies demonstrate
that the non-polar parts (vdW + ESURF) prevail over the com-
bined polar electrostatic contributions (EEL + EGB), thus repre-
senting the driving force for the binding, although a single most
dominant promoting contribution is exerted by the gas-phase
electrostatic component (EEL). On the other hand, the binding
of the apoCP form is also favorable for both subunits, but the
calculated free energies drop significantly and show notable
asymmetry,9.2 kcal mol1 for the subunit A and3.6 kcal mol1
for the subunit B. We attribute this to a decrease in the favor-
able non-polar contributions relative to the holoCP forms. More
precisely, a non-polar contribution for the formation of holoCP:Bj
Gly:CP ligase 1 complex is approximately 120 kcal mol1,
while for apoCP it assumes around 95 kcal mol1. The overall
thermodynamic parameters suggest that there is no competi-
tion between holoCP and apoCP for the binding to ligase,
meaning that when both forms are present, the ligase will
exclusively bind the former system. These results are perfectly
in line with the experimental data by Mocˇibob et al.,15 which
demonstrated that the acylation of holoCP protein to holoCP–Gly
is not, in any way, affected by the presence of the apoCP form,
even by adding a large excess of the latter. What is particularly
Table 2 Calculated binding free energies (DGbind) and their components
a for ACP and prosthetic group interaction with the ligase obtained by the
MM–GBSA approach (in kcal mol1)
System vdW EEL EGB ESURF DHgas DHsolv DHbind TDS DGbind
holoCP:ligase (subunit A) 107.2 378.5 420.1 12.9 485.7 407.2 78.5 57.8 20.7
holoCP:ligase (subunit B) 104.5 364.4 412.3 12.4 468.9 399.9 69.0 49.9 19.1
apoCP:ligase (subunit A) 70.8 245.3 288.1 8.4 316.2 279.7 36.5 27.2 9.2
apoCP:ligase (subunit B) 84.4 228.0 271.0 9.3 312.4 261.6 50.7 47.1 3.6
holoCP–Gly:ligase (subunit A) 82.3 207.2 240.8 13.2 289.5 227.6 61.9 64.8 2.9
holoCP–Gly:ligase (subunit B) 67.2 163.4 200.6 11.8 230.6 188.8 41.8 62.9 20.9
Ppant:ligase (subunit A) 36.9 157.5 160.6 5.9 194.3 154.6 39.7 27.5 12.2
Ppant:ligase (subunit B) 38.3 170.5 176.0 5.9 208.8 170.1 38.7 29.3 10.4
Ppant–Gly:ligase (subunit A) 41.7 122.2 132.2 6.2 163.9 126.1 37.9 32.7 5.2
Ppant–Gly:ligase (subunit B) 37.6 81.8 107.1 5.6 119.5 101.5 17.9 20.7 2.8
a vdW = van der Waals contribution fromMM; EEL = electrostatic energy as calculated by the MM force field; EGB = electrostatic contribution to the
solvation free energy calculated by GB; ESURF = nonpolar contribution to the solvation free energy calculated by an empirical model.
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interesting is the fact that, upon the glycation of the Ppant
prosthetic group, the binding free energies for the holoCP–Gly
form assume positive values, 2.9 kcal mol1 for the subunit A,
and 20.9 kcal mol1, being largely positive for the subunit B.
Although the origin of such a large difference in binding
energies for each subunit is presently unclear, these results
convincingly suggest that the enzymatic attachment of the glycyl
moiety to the carrier protein will strongly promote the dissocia-
tion of both holoCP–Gly proteins from the Bj Gly:CP ligase 1,
indicating that the departure of both CPs is not concerted. Let us
also mention that, although the reliability of the correlation
between in silico and experimental binding free energies is
enhanced when the entropy is included, one should bear in
mind that the calculation of the entropic contribution (TDS) is
still prone to errors and may introduce significant uncertainty
in the results.42,43 In line with these observations, we noticed
that our calculated results for the binding of the holoCP form
(DGbind = 20.7 and 19.1 kcal mol1) seem to be slightly
overestimated in comparison with the experimental result of
6.4 kcal mol1, as calculated from the measured value of KD =
21.5 mM, but the trend between the three forms of the carrier
protein should be qualitatively reliable,44,45 which is the focus
here. Future quantitative improvement might include the multiple
trajectory protocol,46 which requires separate MD simulations for
the unbound partners. This approach is computationally signifi-
cantly more demanding and is beyond the scope here.
3.2 Binding analysis at the protein–protein interface
To get a further insight into the protein–protein binding inter-
face and the resulting interactions, we employed in silico alanine
scanning mutagenesis. All non-alanine and non-glycine residues
in the CP-binding helix in both ligase subunits were mutated to
alanine, including Arg220, Val221, Gln223, Met224, Lys225,
Val227, Ser228, Gln229, Lys230, Gln231, and Gln232, assessing
the influence of these point mutations on the total interaction
energies with the holoCP. Calculations have revealed (Table S1,
ESI,† Fig. 5) that almost all mutations identified these sites as
‘‘hot spot’’ residues, since they reduce the overall binding free
energies by more than 1.36 kcal mol1, which is equivalent to a
10-fold decrease in the KD value, the only exceptions provided by
Val221, Gln223, Lys225, and Gln229 in subunit A and Val221 in
subunit B. Interestingly, the K230A mutation in subunit B even
increased the overall binding energy relative to the wild-type
enzyme by 0.8 kcal mol1. Common to both subunits is the large
influence of the Arg220 residue, which, upon mutation, reduces
the interaction in subunits A and B by 10.2 and 14.2 kcal mol1,
respectively, suggesting the significant role of Arg220 in the
recognition and binding (see later). This large influence is
attributed to a big drop in the electrostatic and solvation
components of the overall DGbind value (Table S1, ESI†), which
is a direct consequence of replacing a charged residue (Arg)
with the uncharged apolar alternative (Ala). These high values
are matched by a double-digit influence of the Lys230 and
Gln231 in the subunit A, while the second-largest effect in the
subunit B is exerted by Met224, being 7.5 kcal mol1. Let us also
mention that Lys230 and Gln231 are placed at the C-terminus
of the CP-binding helix and both form hydrogen bonds with the
side-chain of Glu68, and the backbone oxygen atoms of Val36
and Asp37 of the carrier protein, while Arg220 is placed at the
N-terminus and creates hydrogen bonds with the side-chain of
Glu53, and backbone carbonyl oxygen atoms of the Ile60 and
Gln62 of the carrier protein (Fig. 4).
Apart from inspecting the influence of each residue in
the CP-binding helix on the binding energy through point-
mutations to alanine, a very useful insight into the alterations in
the environment around these residues imposed by the presence
of the ACPs is oﬀered by monitoring the diﬀerences in the pKa
values of the ionisable residues47 in the mentioned ligase region.
A closer look reveals that CP-binding helix is basic in nature
consisting of thirteen amino acids in the RVGQMKAVSQKQQ
sequence, with ionizable residues being Arg220, Lys225 and
Lys230. Two of them, Arg220 and Lys230, are interacting with
carrier proteins, while Lys225 is pointing to the interior of the
ligase and is not directly participating in the interaction (Fig. 4).
Their pKa values (Table 3) were obtained through the PROPKA3.0
server48 on 100 distinct snapshot structures of each complex
attained during the last 5 ns of MD simulations with the 0.05 ns
intervals. The reported pKa values were determined by taking the
average value over all snapshots (Fig. S2, ESI†).49 If one considers
the data for the ‘‘isolated’’ unbound ligase, obtained on the
geometry from the crystal structure (3MF1.pdb), the values for
Arg220 and Lys230 assume the values 13.0 and 9.6, respectively,
suggesting the predominance of their cationic forms. The latter
are only slightly modified relative to their aqueous solution
Fig. 4 Binding interfaces between ligase and various forms of carrier protein, namely apoCP (a), holoCP (b), and holoCP–Gly (c) in the ligase subunit A.
CP-binding helix on ligase is given in yellow, while Bj Gly:CP ligase 1 and carrier proteins are given in transparent blue and red, respectively.
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values of 12.6 and 10.6, respectively. The presence of both
holoCP and holoCP–Gly keeps the pKa value for Arg220 high at
12.6 and 12.7, respectively, being a consequence of the favorable
interactions with the Glu53, Ile60 and Gln62 on the ACP (Fig. 4),
in line with the high hydrogen bonding occupancy of these
interactions (Table 4). This could explain a large negative effect
on binding free energy upon R220A mutation (Fig. 4b), men-
tioned earlier, in comparison to all other mutated residues in
both subunits. These contacts are significantly diminished in
apoCP, which results in a lowering of the Arg220 pKa value to
12.2, thus contributing to the reduced affinity of the ligase
towards the apoCP form. The changes in the pKa values of
Lys230 are less obvious and, regardless of the form of the carrier
protein, are clustered around 10.7 due to stabilizing interactions
with Glu68, mirroring roughly the same occupancies in all three
CP forms (Table 4). The pKa values for the Lys225 are also inde-
pendent of the CP form and are grouped around 8.7, strongly
indicating the hydrophobic nature of the ligase interior.
As previously reported,15 the helix involved in the interaction
with CPs is evolutionary not well preserved and ligases interact
specifically with the cognate carrier protein. The results of
in silico alanine scanning mutagenesis prompted us to re-analyze
the conservation of particular residues (Fig. 6) in the context of
their contribution to the interaction free energy. Curiously, all
the residues with the most pronounced eﬀect on CP binding are
weakly conserved (Met224, Lys230), or not conserved (Arg220,
Gln231, Gln232). The same is also true for other residues with
an appreciable contribution to the free energy of CP binding
(Lys225, Val227, Ser228). The only conserved residue within the
ligase interacting region is Gln229, but it does not influence CP
binding, in accordance with the results of in silico alanine
scanning mutagenesis, because it is located on the opposite
side of the interacting helix and does not contact CPs. Two
conclusions can be drawn from the sequence divergence of the
ligase helix involved in the interaction with CP: no specific
residues are universally conserved to serve as the major anchor-
ing points for CP binding across the whole ligase family, and CP
recognition is likely species dependent. This is in line with
previous experimental results which have shown that recognition
of cognate CPs by A. tumefaciens and B. japonicum is mutually
exclusive, and it can be easily inverted by a domain swap between
the two ligases.15
3.3 Binding modes of the Ppant and Ppant–Gly prosthetic
groups
To get a better insight into the observed exclusive binding
preference of Bj Gly:CP ligase 1 towards holoCP over holoCP–
Gly, we examined the interaction network formed between both
Ppant and Ppant–Gly and their protein surrounding within the
ligase active site. The important hydrogen-bonding interactions
Fig. 5 The enthalpy changes calculated for sequentially mutated inter-
face residue to alanine of complexes formed between holo carrier protein
and Bj Gly:CP ligase 1 in its subunits A (top) and B (bottom).
Table 3 PROPKA pKa values of the residues in the ligase CP-binding helix based on the average value from 100 snapshots of the last 5 ns of the MD
trajectory. pKa,av correspond to the average value over both subunits
Residue
Unbound ligase (ID 3MF1) apoCP:ligase holoCP:ligase holoCP–Gly:ligase
Subunit A Subunit B pKa,av Subunit A Subunit B pKa,av Subunit A Subunit B pKa,av Subunit A Subunit B pKa,av
Arg220 13.0 (Missing residue) — 12.3 12.0 12.2 11.6 13.6 12.6 12.6 12.7 12.7
Lys225 9.3 (Missing residue) — 8.9 8.7 8.8 8.7 8.3 8.5 8.0 9.1 8.6
Lys230 10.3 8.8 9.6 11.0 10.6 10.8 10.6 10.5 10.6 10.7 10.8 10.8
Table 4 Hydrogen bonding analysis between ligase CP-binding helix (donors) and the matching carrier proteins residues (acceptors) at the binding
interface based on the last 30 ns of the MD trajectory
Donor Acceptor Occupancy in apoCP (%) Occupancy in holoCP (%) Occupancy in holoCP–Gly (%)
Residue Group Residue Group Subunit A Subunit B Subunit A Subunit B Subunit A Subunit B
Arg220 N–H1 Ile60 O 45 77 64 73 18 —
Arg220 N–H2 Glu53 OE1 11 — 23 21 26 34
Arg220 N–H2 Glu53 OE2 10 — 30 18 23 34
Arg220 N–H2 Gln62 OE1 7 — 2 11 — —
Lys230 N–H2 Glu68 OE1 31 — — 20 24 15
Lys230 N–H2 Glu68 OE2 22 — — 15 21 8
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with key residues in the last 30 ns of MD trajectories are
presented in Table 5, which suggest that the overall interaction
network is more comprehensive and more persistent for Ppant
than for Ppant–Gly (Fig. S3–S8, ESI†). Within 5 Å of the each
atom of the Ppant prosthetic group in holoCP, we identified the
five most dominant hydrogen bonding networks that promote
the binding, where Ppant acts as a hydrogen bond acceptor to the
side chains of Arg258, Gln232, and Tyr132 through its O1, O2 and
O6 atoms, respectively, and as a hydrogen bond donor to the side
chain of Asp215 through its N(2)–H group (Scheme 1, Fig. S8,
ESI†). Inspection of the evolution of these hydrogen bonds along
the trajectory (Fig. S3–S7, ESI†) reveals that, after the systems
equilibrates, during the last 20–30 ns of the simulations all five of
these interaction distances cluster below 2.5 Å in their donor–
acceptor separation, which qualifies them as medium strong
hydrogen bonds.50,51 Analogously, if we consider the same
distances in the Ppant–Gly group of the holoCP–Gly form, these
interacting partners exhibit significantly larger geometric
separations and lower occupancies, which result in the dimin-
ished stabilization that, subsequently, works in the direction of
dissociating the ACP with such prosthetic group from the
ligase. It appears that the binding interface with Ppant is most
dominated through interactions established by its anionic
phosphate group, where both negatively charged oxygen atoms
are stabilized by the Arg258 side chain, occupying on average
73% and 80% of snapshots in both subunits, the latter being
reduced to 46% and 51% in Ppant–Gly (Table 5). The next in
line are interactions with Asp215 and Tyr132 side chains which
drop from 39% and 63% occupancies in holoCP, respectively,
to 8% and 12% in holoCP–Gly, in the same order. Interestingly,
we did not observe any stabilizing interactions originating from
the hydrogen bonding exerted in the terminal –SH fragment of
Ppant or, even surprisingly, in the analogous –S–C(O)–CH2–NH2
fragment of the glycated Ppant–Gly. This provides another
evidence that glycation of the prosthetic group in holoCP–Gly
does not stabilize the complex and promotes dissociation.
3.4 Contribution of prosthetic groups to the binding
In order to estimate the energy contribution of each form of the
prosthetic group (Ppant or Ppant–Gly) to the overall protein–
protein binding energies, we have modeled two additional
complexes 4 and 5 (Table 1) by deleting protein parts of the
corresponding carrier proteins in 2 and 3, and keeping the
matching prosthetic group with the methyl group on its linker
oxygen atom inside the ligase for additional 60 ns of MD
simulations. It turned out (Table 2) that non-polar contribution
(vdW + ESURF) is favorable but roughly the same for both
prosthetic groups, while electrostatic contribution (EEL + EGB)
is more affirmative for Ppant than for Ppant–Gly. Interestingly,
the latter assume positive values, 4.3 and 17.7 kcal mol1 on
average for PPant and PPant–Gly, respectively, which strongly
point to the overall non-polar hydrophobic nature of the ligase
active site. However, the most interesting are the total DGbind,
which are appreciably more favorable for PPant (11.3 kcal mol1
on average) than for PPant–Gly (1.2 kcal mol1 on average), thus
mirroring the situation with the entire CPs. In the context of the
total protein–protein binding affinities, the result for PPant
suggests that a significant part of the ligase specificity towards
holoCP originates from the stabilization of this form of the
prosthetic group within its active site, which is a noteworthy
outcome. However, this is not an exclusive component deter-
mining biological recognition, and one must not neglect differ-
ences in the protein part of each CP, as evident, for example,
from a set of co-crystallization experiments involving Bj Gly:CP
Fig. 6 Sequence conservation of the amino acid:[carrier protein] ligase residues engaged in aminoacyl carrier protein binding. 180 representative
sequences were used to create multiple sequence alignment, eight of which are shown here. Diﬀerent shades of gray represent 90, 70 and 50%
conservation of identical or similar residues in the full sequence set. The sequence region corresponding to the helix interacting with the CP is boxed. The
numbering on the top of the alignment corresponds to the sequence of the B. japonicum ligase. Abbreviations used and NCBI accession numbers
of representative ligases: B. japonicum, Bradyrhizobium japonicum (NP_767597.1); A. tumefaciens, Agrobacterium tumefaciens (NP_355511.1);
B. dolosa, Burkholderia dolosa (WP_006765793.1); M. extorquens, Methylobacterium extorquens (WP_015952737.1), T. paurometabola, Tsukamurella
paurometabola (WP_013126227.1); S. cattleya, Streptomyces cattleya (WP_014144993.1); B. cereus, Bacillus cereus (WP_000811431.1); C. botulinum,
Clostridium botulinum (WP_003385573.1).
Table 5 Hydrogen bonding analysis between the ligase side-chains and
the prosthetic group of the matching carrier protein within the ligase
active site based on the last 30 ns of the MD trajectory
Donor Acceptor
Occupancy in
holoCP (%)
Occupancy in
holoCP–Gly (%)
Residue Group Residue Group
Subunit
A
Subunit
B
Subunit
A
Subunit
B
Arg258 N–H2 Ppant O1 74 72 25 66
Arg258 N–H1 Ppant O2 92 68 52 50
Ppant N2–H Asp215 O1 10 58 0 16
Tyr132 O–H Ppant O6 41 85 0 23
Ppant O4–H His260 N 2 10 0 0
Gln232 N–H Ppant O2 60 0 1 15
Gln229 N–H Ppant O5 7 0 81 84
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ligase 1 and coenzyme A, an in vivo precursor of the Ppant
group, which resulted in the unproductive binding.52 All of this
strongly indicates that the overall recognition between studied
proteins is jointly affected by differences in the non-covalent
interactions within binding areas and those in the ligase active
site, and that each modification of carrier proteins, even in
their prosthetic groups, results in distinct forms suitable for the
specific binding with the cognate protein partner.
4. Conclusion
In this work we utilized molecular dynamics simulations, MM–
GBSA binding free energy calculations, in silico alanine scanning
mutagenesis, pKa analysis, and multiple sequence alignment to
model the biological interactions of three forms of the aminoacyl
carrier protein, namely holoCP, apoCP, and holoCP–Gly, with their
partner protein Bj Gly:CP ligase 1. The results revealed that the
ligase preferentially binds the holoCP form to both of its subunits
with the binding free energies of 20.7 and 19.1 kcal mol1. On
the other hand, the apoCP form without the Ppant prosthetic
group is also recognized by the ligase, DGbind assuming 9.2 and
3.6 kcal mol1. The observed large difference between binding
affinities of these two forms indicates the lack of competition
between apo- and holo-forms for the ligase binding. After the
prosthetic group is glycylated, the holoCP–Gly form dissociates
from the complex towards its downstream partner protein, as
Ppant–Gly is no longer engaged in interactions established
between unmodified Ppant and its protein surrounding. This is
in agreement with the observed endergonic binding free energies
being 2.9 and 20.9 kcal mol1. It is particularly interesting to see
that such a small modification of the prosthetic group results in
such a significant change in the binding affinities. Earlier experi-
ments have shown that Bj Gly:CP ligase 1 does not aminoacylate
the carrier protein prototype, holoACP of the fatty acid synthesis
pathway (FAS II), despite the presence of the Ppant prosthetic
group.53 Taken all together, this indicates that the attachment of
the Ppant prosthetic group is an obligatory event that precedes the
formation of the biologically active CP:Bj Gly:CP ligase 1 complex,
but the prosthetic group per se is not the element which exclusively
predetermines association. The latter was further revealed by
analyzing complexes involving ligase and prosthetic groups alone,
which confirmed more favorable binding affinities for Ppant than
for Ppant–Gly. However, the productive protein–protein commu-
nication is also guided by the electrostatic complementarity
manifested through the Arg220–Glu53 ion pair and the overall
non-polar interplay of the interacting residues within the
protein–protein binding interface. Evolutionary analysis revealed
that CP recognition is species dependent and there are no
specific residues that are universally conserved and that serve
as the anchoring points for carrier protein binding across the
whole ligase family. Therefore, each structural modification
of the carrier protein results in its altered propensity towards
one of the many heterologous protein partners and, moreover,
prevents the false or nonproductive contact between numerous
non-partner enzymes.
Acknowledgements
We would like to thank the Zagreb University Computing Centre
(SRCE) for generously granting computational resources on the
ISABELLA cluster (isabella.srce.hr) and the CRO–NGI infrastruc-
ture (www.cro-ngi.hr). A.M. wishes to thank the Croatian Science
Foundation for a doctoral stipend through the Career Develop-
ment Project for Young Researchers (Contract No. I-3376-2014).
I.G.S. acknowledges support from the Croatian Science Founda-
tion (Grant 09.01/293) and the European Community’s Seventh
Framework Programme (FP7RegPot/IntegraLife, 315997). R.V.
gratefully acknowledges the European Commission for a Marie
Curie FP7 Career Integration Grant (Contract No. PCIG12-GA-
2012-334493).
References
1 M. S. Anderson and C. R. Raetz, J. Biol. Chem., 1987,
267, 5159.
2 S. W. Jordan and J. E. Cronan, Jr., J. Biol. Chem., 1997,
272, 17903.
3 M. S. Anderson, C. E. Bulawa and C. R. Raetz, J. Biol. Chem.,
1985, 260, 15536.
4 A. L. Schaefer, D. L. Val, B. L. Hanzelka, J. E. Cronan, Jr. and
E. P. Greenberg, Proc. Natl. Acad. Sci. U. S. A., 1996, 93, 9505.
5 J. P. Issartel, V. Koronakis and C. Hughes, Nature, 1991,
351, 759.
6 D. M. Byers and E. A. Meighen, Proc. Natl. Acad. Sci. U. S. A.,
1985, 82, 6085.
7 A. Koglin and C. T. Walsh, Nat. Prod. Rep., 2009, 26, 987.
8 R. S. Gokhale, R. Sankaranarayanan and D. Mohanty,
Curr. Opin. Struct. Biol., 2007, 17, 736.
9 G. Butland, J. M. Peregrin-Alvarez, J. Li, W. Yang, X. Yang,
V. Canadien, A. Starostine, D. Richards, B. Beattie, N. Krogan,
M. Davey, J. Parkinson, J. Greenblatt and A. Emil, Nature,
2005, 433, 531.
10 T. A. Gould, H. P. Schweizer and M. E. Churchill, Mol.
Microbiol., 2004, 53, 1135.
11 Y. M. Zhang, M. S. Rao, R. J. Heath, A. C. Price, A. J. Olson,
C. O. Rock and S. W. White, J. Biol. Chem., 2001, 276, 8231.
12 Y. M. Zhang, B. Wu, J. Zheng and C. O. Rock, J. Biol. Chem.,
2003, 278, 52935.
13 K. D. Parris, L. Lin, A. Tama, R. Mathewa, J. Hixonb,
M. Stahla, C. C. Fritzb, J. Seehraa and W. S Somersa,
Structure, 2000, 8, 883.
14 H. Gong, A. Murphy, C. R. McMaster and D. M. Byers, J. Biol.
Chem., 2007, 282, 4494.
15 M. Mocˇibob, N. Ivic´, M. Luic´ and I. Weygand-Ðurasˇevic´,
Structure, 2013, 21, 614.
16 J. Yang, R. Yan, A. Roy, D. Xu, J. Poisson and Y. Zhang,
Nat. Methods, 2015, 12, 7.
17 A. Roy, A. Kucukural and Y. Zhang, Nat. Protoc., 2010, 5, 725.
18 Y. Zhang, BMC Bioinf., 2008, 9, 40.
19 D. A. Case, T. A. Darden, T. E. Cheatham III, C. L.
Simmerling, J. Wang, R. E. Duke, R. Luo, R. C. Walker,
W. Zhang, K. M. Merz, B. Roberts, S. Hayik, A. Roitberg,
Paper PCCP
19038 | Phys. Chem. Chem. Phys., 2015, 17, 19030--19038 This journal is© the Owner Societies 2015
G. Seabra, J. Swails, A. W. Goetz, I. Kolossvai, K. F. Wong,
F. Paesani, J. Vanicek, R. M. Wolf, J. Liu, X. Wu, S. R. Brozell,
T. Steinbrecher, H. Gohlke, Q. Cai, X. Ye, J. Wang,
M.-J. Hsieh, G. Cui, D. R. Roe, D. H. Mathews, M. G.
Seetin, R. Salomon-Ferrer, C. Sagui, V. Babin, T. Luchko,
S. Gusarov, A. Kovalenko and P. A. Kollman, AMBER 12,
University of California, San Francisco, 2012.
20 M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria,
M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone,
B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato,
X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng,
J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda,
J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao,
H. Nakai, T. Vreven, J. A. Montgomery Jr, J. E. Peralta,
F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers,
K. N. Kudin, V. N. Staroverov, R. Kobayashi, J. Normand,
K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar,
J. Tomasi, M. Cossi, N. Rega, J. M. Millam, M. Klene,
J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo,
R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin,
R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin,
K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador,
O. Farkas, J. J. Dannenberg, S. Dapprich, A. D. Daniels,
J. B. Foresman, J. V. Ortiz, J. Cioslowski and D. J. Fox, Gaussian,
Inc., Wallingford, CT, 2009.
21 C. I. Bayly, P. Cieplak and P. A. Kollman, J. Phys. Chem.,
1993, 97, 10269.
22 J. Wang, R. M. Wolf, J. W. Caldwell, P. A. Kollman and
D. A. Case, J. Comput. Chem., 2004, 25, 1157.
23 V. Hornak, R. Abel, A. Okur, B. Strockbine, A. Roitberg and
C. Simmerling, Proteins: Struct., Funct., Bioinf., 2006,
65, 712.
24 A. W. Gotz, M. J. Williamson, D. Xu, D. Poole, S. Le Grand
and R. C. Walker, J. Chem. Theory Comput., 2012, 9, 1542.
25 S. Le Grand, A. W. Gotz and R. C. Walker, Comput. Phys.
Commun., 2013, 184, 374.
26 R. Salomon-Ferrer, A. W. Goetz, D. Poole, S. Le Grand and
R. C. Walker, J. Chem. Theory Comput., 2013, 9, 3878.
27 J. P. Ryckaert, G. Ciccotti and H. J. C. Berendsen, J. Comput.
Phys., 1997, 23, 327.
28 T. Darden, D. York and L. Pedersen, J. Chem. Phys., 1993,
98, 10089.
29 D. Sitkoﬀ, K. A. Sharp and B. Honig, J. Phys. Chem., 1994,
98, 1978.
30 B. R. Miller III, T. D. McGee, Jr., J. M. Swails, N. Homeyer,
H. Gohlke and A. E. Roitberg, J. Chem. Theory Comput., 2012,
8, 3314.
31 A. Onufriev, D. Bashford and D. A. Case, Proteins, 2004, 55, 383.
32 D. Bashford and D. A. Case, Annu. Rev. Phys. Chem., 2000,
51, 129.
33 I. Massova and P. A. Kollman, J. Am. Chem. Soc., 1999, 121, 8133.
34 S. Huo, I. Massova and P. A. Kollman, J. Comput. Chem.,
2002, 23, 15.
35 T. Clackson and J. A. Wells, Science, 1995, 267, 383.
36 Y. Ofran and B. Rost, PLoS Comput. Biol., 2007, 3, e119.
37 W. L. DeLano, Curr. Opin. Struct. Biol., 2002, 12, 14.
38 D. R. Roe and T. E. Cheatham, J. Chem. Theory Comput.,
2013, 9, 3084.
39 W. Humphrey, A. Dalke and K. Schulten, J. Mol. Graphics,
1996, 14, 33.
40 The PyMOL Molecular Graphics System, Version 1.2r3pre,
Schro¨dinger, LLC.
41 P. J. Turner, Center for Coastal and Land-Margin Research
Oregon Graduate Institute of Science and Technology
Beaverton, Oregon.
42 T. Hou, J. Wang, Y. Li and W. Wang, J. Chem. Inf. Model.,
2011, 51, 69.
43 G. Rastelli, A. D. Rio, G. Degliesposti and M. Sgobba,
J. Comput. Chem., 2010, 31, 797–810.
44 H. Sun, Y. Li, S. Tian, L. Xu and T. Hou, Phys. Chem. Chem.
Phys., 2014, 16, 16719.
45 X. Kong, P. Pan, D. Li, S. Tian, Y. Li and T. Hou, Phys. Chem.
Chem. Phys., 2015, 17, 6098.
46 N. Homeyer and H. Gohlke, Mol. Inf., 2012, 31, 114–122.
47 P. J. Kundrotas and E. Alexov, Biophys. J., 2006, 9, 1724.
48 M. H. M. Olsson, C. R. Sondergard, M. Rostkowski and
J. H. Jensen, J. Chem. Theory Comput., 2010, 7, 525.
49 H. W. van Vlijmen, M. Schaefer and M. Karplus, Proteins,
1998, 33, 145.
50 P. Gilli, L. Pretto, V. Bertolasi and G. Gilli, Acc. Chem. Res.,
2009, 42, 33.
51 C. Laurence and M. Berthelot, Perspect. Drug Discovery Des.,
2000, 18, 39.
52 M. Mocˇibob, N. Ivic´, D. Sˇubasˇic´, M. Luic´ and I. Weygand-
Ðurasˇevic´, Croat. Chem. Acta, 2011, 84, 149.
53 M. Mocˇibob, N. Ivic´, S. Bilokapic´, T. Maier, M. Luic´, N. Ban
and I. Weygand-Ðurasˇevic´, Proc. Natl. Acad. Sci. U. S. A.,
2010, 107, 14585.
PCCP Paper
